"Franciscan Health Olympia Fields is an approved Teaching Hospital Cancer Program by the Commission on Cancer and at the forefront in services for cancer, heart and vascular, colorectal and diabetes."

During the past decade, Franciscan St. James Health-Olympia Fields Campus conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 4 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 1 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Franciscan St. James Health-Olympia Fields Campus" #1 collaborator was "Cancer and Leukemia Group B" with 2 trials as a collaborator, "NCIC Clinical Trials Group" with 2 trials as a collaborator, "SWOG Cancer Research Network" with 2 trials as a collaborator, "American College of Surgeons" with 1 trials as a collaborator and "NSABP Foundation Inc" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 8 trials.

According to Clinical.Site data, the most researched conditions in "Franciscan St. James Health-Olympia Fields Campus" are "Acute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome" (1 trials), "Adult Acute Megakaryoblastic Leukemia" (1 trials), "Adult Acute Monocytic Leukemia" (1 trials), "Adult Acute Myeloid Leukemia With Inv(16)(p13.1q22); CBFB-MYH11" (1 trials) and "Adult Acute Myeloid Leukemia With Maturation" (1 trials). Many other conditions were trialed in "Franciscan St. James Health-Olympia Fields Campus" in a lesser frequency.

Most popular intervention types in "Franciscan St. James Health-Olympia Fields Campus" are "Drug" (6 trials), "Other" (4 trials), "Biological" (3 trials), "Radiation" (2 trials) and "Procedure" (1 trials). Other intervention types were less common.

The name of intervention was led by "Laboratory Biomarker Analysis" (4 trials), "Quality-of-Life Assessment" (3 trials), "Bevacizumab" (2 trials), "Cisplatin" (2 trials) and "Anastrozole" (1 trials). Other intervention names were less common.

The vast majority of trials in "Franciscan St. James Health-Olympia Fields Campus" are 3 trials for "All" genders and 3 trials for "Female" genders.

Currently, there are NaN active trials in "Franciscan St. James Health-Olympia Fields Campus". undefined are not yet recruiting, undefined are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 4 completed trials in Franciscan St. James Health-Olympia Fields Campus, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Franciscan St. James Health-Olympia Fields Campus, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 5 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".